# RAG Benchmark — 2026-09-09

## Sonar Prompt 8192

**Q1:** Interviewer: Thanks for taking the time. This is for an internal review of decision-making during admissions, and I may ask follow-up questions as we go. Are you comfortable with that? Participant: Yes, that's fine. Interviewer: Can you tell me your role on the team during this admission? Participant: I was the attending on the general medicine service, with a resident rotating through. We picked this patient up on day one after she came in for an unrelated complaint and the monitor flagged something new. Interviewer: What was your overall goal for her care during the stay? Participant: To sort out the new finding properly and get her home with a plan that actually made sense given everything else going on with her, not just the one issue. Interviewer: Walk me through what happened, from the diagnosis to discharge. Participant: The admission ECG showed persistent atrial fibrillation, new to us. Her CHA2DS2-VASc came out to 4, so meaningful annual stroke risk if she goes untreated. HAS-BLED was 2 — moderate, not a contraindication on its own. Pharmacy checked for interactions with the DOAC we'd typically use and didn't find any, though they flagged her renal function was sitting at the low end of normal and wanted it monitored. The complicating piece was a fall about three weeks earlier. When we asked her about it directly, she said she tripped, but she also mentioned feeling briefly lightheaded right before — and that part had never been worked up anywhere. So we didn't actually know if this was a mechanical trip or something with a cardiac or orthostatic component that nobody had chased down. Given that gap, I asked for a fall-risk assessment and held off committing to a start date until we had more to go on. The formal assessment came back borderline — not clearly low, not clearly high. I also asked cardiology for a curbside opinion on timing anticoagulation after an unexplained pre-fall symptom, and their answer was honestly that the literature doesn't give a clean threshold for a case like this. On day two, one of the nurses mentioned that a patient down the hall had a bleeding complication on anticoagulation the month before. My patient's daughter had heard about it and asked me directly how similar the situations were. I didn't have the other patient's details memorized, so I asked the resident to pull what was available before I answered her — turned out that patient had notably worse renal clearance and was also on an antiplatelet, which changes the picture substantially. That took a day to sort out. By day three, we had that comparison clarified, but her own fall-risk score was still sitting in that borderline zone, and the CHA2DS2-VASc and HAS-BLED numbers hadn't moved — they still leaned toward treating. Discharge was set for the next morning. I asked for one more renal function check before finalizing a dose, since her creatinine had been borderline on admission and I wanted a same-admission number rather than working off something a few days old. On day four, right before discharge, she had a small bruise where blood had been drawn. She wasn't on anticoagulation yet, so it wasn't drug-related, but the renal result still hadn't come back. I finalized the discharge without starting treatment and arranged outpatient follow-up, which ended up being three weeks out rather than the two we'd hoped for. Interviewer: Let's go through each of those points in more detail. At the first one — right after diagnosis — what stood out most? Participant: The lightheadedness before the fall. If that fall had a cardiac cause we hadn't identified, starting anticoagulation without understanding it felt premature. But I'll be honest, it's a judgment call — plenty of people would say the stroke-risk numbers were clear enough to just start and monitor. Interviewer: What alternatives did you weigh? Participant: Start the DOAC right away given the score, defer until the lightheadedness was evaluated, or start a reduced empirical dose in the meantime. I went with deferring the start date, mainly because the history felt incomplete rather than because I thought waiting was inherently safer. Interviewer: At the second point, with the comparator patient — what were you trying to do there? Participant: Give the daughter an accurate answer instead of a reassuring guess. Without knowing the other patient's renal function or medications, I couldn't tell her anything meaningful, so I had the resident check before we talked further. Interviewer: How much time pressure did that add? Participant: Some — it pushed the conversation back a day, which mattered given discharge planning. But answering her with an unverified comparison seemed worse than the delay. Interviewer: At the third point, after the comparison was clarified and fall risk was still borderline — what was the reasoning behind getting another renal check? Participant: Her creatinine on admission was borderline, and dosing a DOAC on stale numbers, especially this close to discharge, didn't sit right with me. Someone could reasonably argue the scores already justified starting and adjusting later if needed. I didn't feel strongly that one path was clearly correct. Interviewer: Had a similar situation come up for you before? Participant: Something like it, yes — dosing decisions where the renal number is borderline. It usually comes down to how much runway you have before discharge, and here we had very little. Interviewer: At the fourth point, the bruise at discharge — how did that factor in? Participant: It didn't really change anything clinically since she wasn't on the drug yet. The bigger factor was still the pending renal result. We noted the bruise for the outpatient team and moved on. Interviewer: If the fall-risk assessment had come back clearly low instead of borderline, would you have decided differently? Participant: Probably, yes — a clear low score would have resolved a lot of the hesitation at the first decision point. Interviewer: If the comparator patient's chart details had been available immediately, do you think the outcome would have changed? Participant: Possibly the family conversation would have gone faster, but I don't think it would have changed the actual treatment timing much — the renal question was separate. Interviewer: Looking back, what would you tell a colleague facing something similar? Participant: Chase down unexplained symptoms before they get labeled as routine falls, and don't assume a story about another patient applies to yours without checking the details. Beyond that, I think reasonable people could have made different calls at almost every step here.

_ranker=rrf · t=0.04 · k=25 → 25 in context · 8192 ctx · emb 1.58s · gen 103.01s · total 106.7s_

**Retrieved** (ranked by store ranker):
1. **From Mindless to Mindful Practice — Cognitive Bias and Clinical Decision Making.pdf** — 0.0323 (rrf) — _#### june 27, 2013 the resident and the attending physician regarding the management of posterio_
2. **Mitigating cognitive bias with clinical decision support systems  an experimental study.pdf** — 0.0240 (rrf) — _# support Student 52 female (69.3 %) 75 (72.8 %) 25.53 (SD = 5.02) 25 (range = 19–52) 4.57 (SD =_
3. **Journal of Clinical Nursing - 2023 - Jala - Cognitive bias during clinical decision‐making and its influence on patient.pdf** — 0.0213 (rrf) — _# decisionmaking examined the relationship between nurses' bias to healthcare disparities. In th_
4. **Clinical-decision-making--Cognitive-biases-and-heu_2025_The-American-Journal.pdf** — 0.0212 (rrf) — _## Uwe Dulleck, PhD revealed that if a patient was having lower abdominal pain with a temperatur_
5. **Goh et al. (2025) Physician clinical decision modification and bias assessment in a randomized controlled trial of AI assistance.pdf** — 0.0209 (rrf) — _# fi cation ecisionquestions,basedonevidencehttps://doi.org/10.1038/s43856-025-00781-2 sentation_
6. **Cognitive bias and decision aid use under stressful conditions.pdf** — 0.0203 (rrf) — _### cKniff At the time of this study, CDSS were available to nurses in the form of computers and_
7. **Vicente & Matute (2023) Humans inherit artificial intelligence biases.pdf** — 0.0188 (rrf) — _# Experiment 1 Method. the methodology reported in this article and the experiments were conduct_
8. **natesan-et-al-2016-cognitive-bias-in-usability-testing.pdf** — 0.0186 (rrf) — _## Types of Cognitive Biases with?” vs. “What did you think of the material the device was made _
9. **Azzopardi (2021). Cognitive Biases in Search.pdf** — 0.0185 (rrf) — _# 4 DISCUSSION AND CRITICAL REFLECTION | was deemed as not helpful. So, if a participant said it_
10. **Vicente & Matute (2023) Humans inherit artificial intelligence biases.pdf** — 0.0183 (rrf) — _# Experiment 3 e postexperimental questions in Experiment 3 were the same as in Experiment 2, bu_
11. **Cognitive bias in the cockpit A deadly false sense of normality Sam OConnor (1).pdf** — 0.0180 (rrf) — _# 1. Introduction th On the evening of 7 board was on final approach to runway 28 Right in San F_
12. **Cognitive bias in the cockpit A deadly false sense of normality Sam OConnor (1).pdf** — 0.0179 (rrf) — _# 6. Conclusion fter a gap in the research was discovered aimed to establish what the most commo_
13. **Rastogi et al. (2022) Deciding fast and slow_The role of cognitive biases in AI-assisted decision-making.pdf** — 0.0173 (rrf) — _# 4 Anchoring bias Figure 2. Results of experiment 1. time allocations in experiment 1. answer u_
14. **Cognitive bias in the cockpit A deadly false sense of normality Sam OConnor (1).pdf** — 0.0170 (rrf) — _# 5. Discussion conditions (14 out of 25) finding, t he researcher disproportionately if a large_
15. **Bucinca et al. (2021) To Trust or to Think_Cognitive Forcing Functions Can Reduce Overreliance on AI in AI-assisted Decision-making.pdf** — 0.0165 (rrf) — _# 188 task, the top performer of each batch was rewarded with a bonus of $3. Out of 260 particip_
16. **Clinical-decision-making--Cognitive-biases-and-heu_2025_The-American-Journal.pdf** — 0.0164 (rrf) — _## Uwe Dulleck, PhD learnthroughpractice.AsDanielKahnemanarguesinhisbook Fast, and Slow , expert_
17. **Goh et al. (2025) Physician clinical decision modification and bias assessment in a randomized controlled trial of AI assistance.pdf** — 0.0164 (rrf) — _# fi cation 13,14 studies . In either case, our statistical model (Supplementary Table 6) showed_
18. **parasuraman-manzey-2010-complacency-and-bias-in-human-use-of-automation-an-attentional-integration.pdf** — 0.0163 (rrf) — _# Complacency and Bias in Human Use of Automation: An Attentional Integration 400 and management_
19. **natesan-et-al-2016-cognitive-bias-in-usability-testing.pdf** — 0.0161 (rrf) — _## Types of Cognitive Biases criticize themselves rather than the device. Priming Effect. The te_
20. **Mitigating cognitive bias with clinical decision support systems  an experimental study.pdf** — 0.0160 (rrf) — _# support were adapted from translated into German scenario in less the use of heuristics for on_
21. **parasuraman-manzey-2010-complacency-and-bias-in-human-use-of-automation-an-attentional-integration.pdf** — 0.0160 (rrf) — _# Complacency and Bias in Human Use of Automation: An Attentional Integration - 402 discounting _
22. **Journal of Clinical Nursing - 2023 - Jala - Cognitive bias during clinical decision‐making and its influence on patient.pdf** — 0.0159 (rrf) — _# 4on patient outcomes in the emergency department: A scoping We used the eligibility and exclus_
23. **Goh et al. (2025) Physician clinical decision modification and bias assessment in a randomized controlled trial of AI assistance.pdf** — 0.0159 (rrf) — _# fi cation afterward. I also felt attack in his early 60 Afterreviewingthecasevignetteandassoci_
24. **Clinical-decision-making--Cognitive-biases-and-heu_2025_The-American-Journal.pdf** — 0.0158 (rrf) — _## Uwe Dulleck, PhD ical decisionmaking \[ The fi ndings of our study have signi patient health _
25. **The_Handbook_of_Evolutionary_Psychology.pdf** — 0.0158 (rrf) — _# to Dangers from Humans speed, brute strength, sensory acuity, and apparent det allies to attac_

{
  "analysis_metadata": {
    "task": "cognitive_bias_analysis",
    "interview_speakers_detected": [
      "Interviewer",
      "Participant"
    ],
    "retrieved_corpus_support_used": false,
    "analysis_scope_note": "Analysis focused on the participant's stated reasoning across four decision episodes: initial anticoagulation timing after new atrial fibrillation, evaluation of a comparator patient's bleeding event, pre-discharge renal function checking, and discharge without starting anticoagulation. No affirmative bias-specific mechanism was identified in the participant's reasoning."
  },
  "identified_bias_summary": [],
  "identified_occurrences": [],
  "candidate_biases": [
    {
      "candidate_id": "cand_001",
      "classification_status": "candidate",
      "proposed_bias_label": "Availability bias",
      "alternative_labels": [
        "availability heuristic"
      ],
      "taxonomy_status": "established_label",
      "speaker_or_attributed_person": "Participant",
      "possible_decision_episode_label": "Interpreting the relevance of another patient's bleeding complication to the current patient's anticoagulation decision",
      "supporting_interview_quote": "On day two, one of the nurses mentioned that a patient down the hall had a bleeding complication on anticoagulation the month before. My patient's daughter had heard about it and asked me directly how similar the situations were.",
      "plausible_mechanism": "A recent and emotionally salient bleeding complication could make anticoagulation-related harm more cognitively available, potentially increasing caution in the current patient even if the cases were not clinically comparable.",
      "why_not_identified": "The participant did not act on the comparison before verifying the other patient's details, concluded the cases differed substantially, and stated the comparison probably would not have changed treatment timing. No affirmative evidence indicates the availability of the bleeding complication distorted the participant's reasoning or decision."
    },
    {
      "candidate_id": "cand_002",
      "classification_status": "candidate",
      "proposed_bias_label": "Omission bias",
      "alternative_labels": [
        "omission bias",
        "risk aversion",
        "inaction bias"
      ],
      "taxonomy_status": "established_label",
      "speaker_or_attributed_person": "Participant",
      "possible_decision_episode_label": "Deferring direct oral anticoagulant initiation despite CHA2DS2-VASc of 4 and HAS-BLED of 2 because of fall history and borderline renal function",
      "supporting_interview_quote": "I went with deferring the start date, mainly because the history felt incomplete rather than because I thought waiting was inherently safer.",
      "plausible_mechanism": "Omission bias could favor withholding treatment to avoid proximal harms from action over stroke risk from inaction, even when clinical scores lean toward treating.",
      "why_not_identified": "The participant explicitly denied that waiting was inherently safer and gave non-biased clinical reasons, including unexplained pre-fall lightheadedness, borderline renal function, and pending data. No statement demonstrates differential weighting of omission harm versus commission harm."
    }
  ],
  "no_supported_biases_found": true,
  "limitations": [
    "The analysis relies on a single self-reported interview without an independent clinical benchmark or outcome data; no conclusion is made about whether the clinical decisions were correct.",
    "Several cautious decisions were clinically reasonable under uncertainty, and bias was not inferred from poor outcomes, disagreement, time pressure, insufficient information, or ordinary uncertainty alone.",
    "Retrieved corpus support was not used for any positively identified occurrence because no occurrence met the threshold for identification.",
    "The candidate biases listed are plausible but lack sufficient affirmative evidence in the interview for identification even at low confidence."
  ]
}

## Sonnet Prompt 8192

**Q1:** Interviewer: Thanks for taking the time. This is for an internal review of decision-making during admissions, and I may ask follow-up questions as we go. Are you comfortable with that? Participant: Yes, that's fine. Interviewer: Can you tell me your role on the team during this admission? Participant: I was the attending on the general medicine service, with a resident rotating through. We picked this patient up on day one after she came in for an unrelated complaint and the monitor flagged something new. Interviewer: What was your overall goal for her care during the stay? Participant: To sort out the new finding properly and get her home with a plan that actually made sense given everything else going on with her, not just the one issue. Interviewer: Walk me through what happened, from the diagnosis to discharge. Participant: The admission ECG showed persistent atrial fibrillation, new to us. Her CHA2DS2-VASc came out to 4, so meaningful annual stroke risk if she goes untreated. HAS-BLED was 2 — moderate, not a contraindication on its own. Pharmacy checked for interactions with the DOAC we'd typically use and didn't find any, though they flagged her renal function was sitting at the low end of normal and wanted it monitored. The complicating piece was a fall about three weeks earlier. When we asked her about it directly, she said she tripped, but she also mentioned feeling briefly lightheaded right before — and that part had never been worked up anywhere. So we didn't actually know if this was a mechanical trip or something with a cardiac or orthostatic component that nobody had chased down. Given that gap, I asked for a fall-risk assessment and held off committing to a start date until we had more to go on. The formal assessment came back borderline — not clearly low, not clearly high. I also asked cardiology for a curbside opinion on timing anticoagulation after an unexplained pre-fall symptom, and their answer was honestly that the literature doesn't give a clean threshold for a case like this. On day two, one of the nurses mentioned that a patient down the hall had a bleeding complication on anticoagulation the month before. My patient's daughter had heard about it and asked me directly how similar the situations were. I didn't have the other patient's details memorized, so I asked the resident to pull what was available before I answered her — turned out that patient had notably worse renal clearance and was also on an antiplatelet, which changes the picture substantially. That took a day to sort out. By day three, we had that comparison clarified, but her own fall-risk score was still sitting in that borderline zone, and the CHA2DS2-VASc and HAS-BLED numbers hadn't moved — they still leaned toward treating. Discharge was set for the next morning. I asked for one more renal function check before finalizing a dose, since her creatinine had been borderline on admission and I wanted a same-admission number rather than working off something a few days old. On day four, right before discharge, she had a small bruise where blood had been drawn. She wasn't on anticoagulation yet, so it wasn't drug-related, but the renal result still hadn't come back. I finalized the discharge without starting treatment and arranged outpatient follow-up, which ended up being three weeks out rather than the two we'd hoped for. Interviewer: Let's go through each of those points in more detail. At the first one — right after diagnosis — what stood out most? Participant: The lightheadedness before the fall. If that fall had a cardiac cause we hadn't identified, starting anticoagulation without understanding it felt premature. But I'll be honest, it's a judgment call — plenty of people would say the stroke-risk numbers were clear enough to just start and monitor. Interviewer: What alternatives did you weigh? Participant: Start the DOAC right away given the score, defer until the lightheadedness was evaluated, or start a reduced empirical dose in the meantime. I went with deferring the start date, mainly because the history felt incomplete rather than because I thought waiting was inherently safer. Interviewer: At the second point, with the comparator patient — what were you trying to do there? Participant: Give the daughter an accurate answer instead of a reassuring guess. Without knowing the other patient's renal function or medications, I couldn't tell her anything meaningful, so I had the resident check before we talked further. Interviewer: How much time pressure did that add? Participant: Some — it pushed the conversation back a day, which mattered given discharge planning. But answering her with an unverified comparison seemed worse than the delay. Interviewer: At the third point, after the comparison was clarified and fall risk was still borderline — what was the reasoning behind getting another renal check? Participant: Her creatinine on admission was borderline, and dosing a DOAC on stale numbers, especially this close to discharge, didn't sit right with me. Someone could reasonably argue the scores already justified starting and adjusting later if needed. I didn't feel strongly that one path was clearly correct. Interviewer: Had a similar situation come up for you before? Participant: Something like it, yes — dosing decisions where the renal number is borderline. It usually comes down to how much runway you have before discharge, and here we had very little. Interviewer: At the fourth point, the bruise at discharge — how did that factor in? Participant: It didn't really change anything clinically since she wasn't on the drug yet. The bigger factor was still the pending renal result. We noted the bruise for the outpatient team and moved on. Interviewer: If the fall-risk assessment had come back clearly low instead of borderline, would you have decided differently? Participant: Probably, yes — a clear low score would have resolved a lot of the hesitation at the first decision point. Interviewer: If the comparator patient's chart details had been available immediately, do you think the outcome would have changed? Participant: Possibly the family conversation would have gone faster, but I don't think it would have changed the actual treatment timing much — the renal question was separate. Interviewer: Looking back, what would you tell a colleague facing something similar? Participant: Chase down unexplained symptoms before they get labeled as routine falls, and don't assume a story about another patient applies to yours without checking the details. Beyond that, I think reasonable people could have made different calls at almost every step here.

_ranker=rrf · t=0.04 · k=25 → 25 in context · 8192 ctx · emb 1.42s · gen 106.85s · total 110.2s_

**Retrieved** (ranked by store ranker):
1. **From Mindless to Mindful Practice — Cognitive Bias and Clinical Decision Making.pdf** — 0.0323 (rrf) — _#### june 27, 2013 the resident and the attending physician regarding the management of posterio_
2. **Mitigating cognitive bias with clinical decision support systems  an experimental study.pdf** — 0.0240 (rrf) — _# support Student 52 female (69.3 %) 75 (72.8 %) 25.53 (SD = 5.02) 25 (range = 19–52) 4.57 (SD =_
3. **Journal of Clinical Nursing - 2023 - Jala - Cognitive bias during clinical decision‐making and its influence on patient.pdf** — 0.0213 (rrf) — _# decisionmaking examined the relationship between nurses' bias to healthcare disparities. In th_
4. **Clinical-decision-making--Cognitive-biases-and-heu_2025_The-American-Journal.pdf** — 0.0212 (rrf) — _## Uwe Dulleck, PhD revealed that if a patient was having lower abdominal pain with a temperatur_
5. **Goh et al. (2025) Physician clinical decision modification and bias assessment in a randomized controlled trial of AI assistance.pdf** — 0.0209 (rrf) — _# fi cation ecisionquestions,basedonevidencehttps://doi.org/10.1038/s43856-025-00781-2 sentation_
6. **Cognitive bias and decision aid use under stressful conditions.pdf** — 0.0203 (rrf) — _### cKniff At the time of this study, CDSS were available to nurses in the form of computers and_
7. **Vicente & Matute (2023) Humans inherit artificial intelligence biases.pdf** — 0.0188 (rrf) — _# Experiment 1 Method. the methodology reported in this article and the experiments were conduct_
8. **natesan-et-al-2016-cognitive-bias-in-usability-testing.pdf** — 0.0186 (rrf) — _## Types of Cognitive Biases with?” vs. “What did you think of the material the device was made _
9. **Azzopardi (2021). Cognitive Biases in Search.pdf** — 0.0185 (rrf) — _# 4 DISCUSSION AND CRITICAL REFLECTION | was deemed as not helpful. So, if a participant said it_
10. **Vicente & Matute (2023) Humans inherit artificial intelligence biases.pdf** — 0.0183 (rrf) — _# Experiment 3 e postexperimental questions in Experiment 3 were the same as in Experiment 2, bu_
11. **Cognitive bias in the cockpit A deadly false sense of normality Sam OConnor (1).pdf** — 0.0180 (rrf) — _# 1. Introduction th On the evening of 7 board was on final approach to runway 28 Right in San F_
12. **Cognitive bias in the cockpit A deadly false sense of normality Sam OConnor (1).pdf** — 0.0179 (rrf) — _# 6. Conclusion fter a gap in the research was discovered aimed to establish what the most commo_
13. **Rastogi et al. (2022) Deciding fast and slow_The role of cognitive biases in AI-assisted decision-making.pdf** — 0.0173 (rrf) — _# 4 Anchoring bias Figure 2. Results of experiment 1. time allocations in experiment 1. answer u_
14. **Cognitive bias in the cockpit A deadly false sense of normality Sam OConnor (1).pdf** — 0.0170 (rrf) — _# 5. Discussion conditions (14 out of 25) finding, t he researcher disproportionately if a large_
15. **Bucinca et al. (2021) To Trust or to Think_Cognitive Forcing Functions Can Reduce Overreliance on AI in AI-assisted Decision-making.pdf** — 0.0165 (rrf) — _# 188 task, the top performer of each batch was rewarded with a bonus of $3. Out of 260 particip_
16. **Clinical-decision-making--Cognitive-biases-and-heu_2025_The-American-Journal.pdf** — 0.0164 (rrf) — _## Uwe Dulleck, PhD learnthroughpractice.AsDanielKahnemanarguesinhisbook Fast, and Slow , expert_
17. **Goh et al. (2025) Physician clinical decision modification and bias assessment in a randomized controlled trial of AI assistance.pdf** — 0.0164 (rrf) — _# fi cation 13,14 studies . In either case, our statistical model (Supplementary Table 6) showed_
18. **parasuraman-manzey-2010-complacency-and-bias-in-human-use-of-automation-an-attentional-integration.pdf** — 0.0163 (rrf) — _# Complacency and Bias in Human Use of Automation: An Attentional Integration 400 and management_
19. **natesan-et-al-2016-cognitive-bias-in-usability-testing.pdf** — 0.0161 (rrf) — _## Types of Cognitive Biases criticize themselves rather than the device. Priming Effect. The te_
20. **Mitigating cognitive bias with clinical decision support systems  an experimental study.pdf** — 0.0160 (rrf) — _# support were adapted from translated into German scenario in less the use of heuristics for on_
21. **parasuraman-manzey-2010-complacency-and-bias-in-human-use-of-automation-an-attentional-integration.pdf** — 0.0160 (rrf) — _# Complacency and Bias in Human Use of Automation: An Attentional Integration - 402 discounting _
22. **Journal of Clinical Nursing - 2023 - Jala - Cognitive bias during clinical decision‐making and its influence on patient.pdf** — 0.0159 (rrf) — _# 4on patient outcomes in the emergency department: A scoping We used the eligibility and exclus_
23. **Goh et al. (2025) Physician clinical decision modification and bias assessment in a randomized controlled trial of AI assistance.pdf** — 0.0159 (rrf) — _# fi cation afterward. I also felt attack in his early 60 Afterreviewingthecasevignetteandassoci_
24. **Clinical-decision-making--Cognitive-biases-and-heu_2025_The-American-Journal.pdf** — 0.0158 (rrf) — _## Uwe Dulleck, PhD ical decisionmaking \[ The fi ndings of our study have signi patient health _
25. **The_Handbook_of_Evolutionary_Psychology.pdf** — 0.0158 (rrf) — _# to Dangers from Humans speed, brute strength, sensory acuity, and apparent det allies to attac_

{
  "analysis_metadata": {
    "task": "cognitive_bias_analysis",
    "interview_speakers_detected": [
      "Interviewer",
      "Participant"
    ],
    "retrieved_corpus_support_used": false,
    "analysis_scope_note": "Mechanism-first review of the participant's reasoning. No bias-specific mechanism met the affirmative-evidence threshold for identification; plausible risk-related biases are recorded as candidates only."
  },
  "identified_bias_summary": [],
  "identified_occurrences": [],
  "candidate_biases": [
    {
      "candidate_id": "cand_001",
      "classification_status": "candidate",
      "proposed_bias_label": "Omission bias",
      "alternative_labels": [
        "Status quo bias",
        "Inaction bias"
      ],
      "taxonomy_status": "established_label",
      "speaker_or_attributed_person": "Participant",
      "possible_decision_episode_label": "Discharge without starting anticoagulation despite CHA2DS2-VASc 4",
      "supporting_interview_quote": "I finalized the discharge without starting treatment and arranged outpatient follow-up, which ended up being three weeks out rather than the two we'd hoped for.",
      "plausible_mechanism": "A preference for inaction or delay over starting anticoagulation may be driven by greater anticipated regret or blame for bleeding complications than for thromboembolic events, despite stroke-risk scores favoring treatment.",
      "why_not_identified": "No affirmative transcript evidence shows the choice was driven by an omission/status-quo mechanism rather than unresolved renal function, borderline fall-risk assessment, and incomplete history; the participant explicitly stated waiting was not considered inherently safer."
    },
    {
      "candidate_id": "cand_002",
      "classification_status": "candidate",
      "proposed_bias_label": "Availability heuristic",
      "alternative_labels": [],
      "taxonomy_status": "established_label",
      "speaker_or_attributed_person": "Participant",
      "possible_decision_episode_label": "Consideration of comparator patient with recent anticoagulation-related bleeding",
      "supporting_interview_quote": "On day two, one of the nurses mentioned that a patient down the hall had a bleeding complication on anticoagulation the month before.",
      "plausible_mechanism": "A recent, vivid bleeding complication on the same ward could increase the mental availability of anticoagulation harm and influence risk perception.",
      "why_not_identified": "The participant did not act on this salience; he requested the comparator patient's details, identified clinically meaningful differences, and reported the comparison did not materially change the treatment decision."
    }
  ],
  "no_supported_biases_found": true,
  "limitations": [
    "Retrieved corpus passages mainly address general medical cognitive bias and did not provide direct support for any affirmative bias occurrence in this interview.",
    "Retrospective self-report cannot rule out implicit or unstated bias, but the conservative standard requires affirmative mechanism-specific evidence.",
    "The transcript contains substantial clinical uncertainty; uncertainty alone was not treated as bias."
  ]
}

## Gemini Prompt 8192

**Q1:** Interviewer: Thanks for taking the time. This is for an internal review of decision-making during admissions, and I may ask follow-up questions as we go. Are you comfortable with that? Participant: Yes, that's fine. Interviewer: Can you tell me your role on the team during this admission? Participant: I was the attending on the general medicine service, with a resident rotating through. We picked this patient up on day one after she came in for an unrelated complaint and the monitor flagged something new. Interviewer: What was your overall goal for her care during the stay? Participant: To sort out the new finding properly and get her home with a plan that actually made sense given everything else going on with her, not just the one issue. Interviewer: Walk me through what happened, from the diagnosis to discharge. Participant: The admission ECG showed persistent atrial fibrillation, new to us. Her CHA2DS2-VASc came out to 4, so meaningful annual stroke risk if she goes untreated. HAS-BLED was 2 — moderate, not a contraindication on its own. Pharmacy checked for interactions with the DOAC we'd typically use and didn't find any, though they flagged her renal function was sitting at the low end of normal and wanted it monitored. The complicating piece was a fall about three weeks earlier. When we asked her about it directly, she said she tripped, but she also mentioned feeling briefly lightheaded right before — and that part had never been worked up anywhere. So we didn't actually know if this was a mechanical trip or something with a cardiac or orthostatic component that nobody had chased down. Given that gap, I asked for a fall-risk assessment and held off committing to a start date until we had more to go on. The formal assessment came back borderline — not clearly low, not clearly high. I also asked cardiology for a curbside opinion on timing anticoagulation after an unexplained pre-fall symptom, and their answer was honestly that the literature doesn't give a clean threshold for a case like this. On day two, one of the nurses mentioned that a patient down the hall had a bleeding complication on anticoagulation the month before. My patient's daughter had heard about it and asked me directly how similar the situations were. I didn't have the other patient's details memorized, so I asked the resident to pull what was available before I answered her — turned out that patient had notably worse renal clearance and was also on an antiplatelet, which changes the picture substantially. That took a day to sort out. By day three, we had that comparison clarified, but her own fall-risk score was still sitting in that borderline zone, and the CHA2DS2-VASc and HAS-BLED numbers hadn't moved — they still leaned toward treating. Discharge was set for the next morning. I asked for one more renal function check before finalizing a dose, since her creatinine had been borderline on admission and I wanted a same-admission number rather than working off something a few days old. On day four, right before discharge, she had a small bruise where blood had been drawn. She wasn't on anticoagulation yet, so it wasn't drug-related, but the renal result still hadn't come back. I finalized the discharge without starting treatment and arranged outpatient follow-up, which ended up being three weeks out rather than the two we'd hoped for. Interviewer: Let's go through each of those points in more detail. At the first one — right after diagnosis — what stood out most? Participant: The lightheadedness before the fall. If that fall had a cardiac cause we hadn't identified, starting anticoagulation without understanding it felt premature. But I'll be honest, it's a judgment call — plenty of people would say the stroke-risk numbers were clear enough to just start and monitor. Interviewer: What alternatives did you weigh? Participant: Start the DOAC right away given the score, defer until the lightheadedness was evaluated, or start a reduced empirical dose in the meantime. I went with deferring the start date, mainly because the history felt incomplete rather than because I thought waiting was inherently safer. Interviewer: At the second point, with the comparator patient — what were you trying to do there? Participant: Give the daughter an accurate answer instead of a reassuring guess. Without knowing the other patient's renal function or medications, I couldn't tell her anything meaningful, so I had the resident check before we talked further. Interviewer: How much time pressure did that add? Participant: Some — it pushed the conversation back a day, which mattered given discharge planning. But answering her with an unverified comparison seemed worse than the delay. Interviewer: At the third point, after the comparison was clarified and fall risk was still borderline — what was the reasoning behind getting another renal check? Participant: Her creatinine on admission was borderline, and dosing a DOAC on stale numbers, especially this close to discharge, didn't sit right with me. Someone could reasonably argue the scores already justified starting and adjusting later if needed. I didn't feel strongly that one path was clearly correct. Interviewer: Had a similar situation come up for you before? Participant: Something like it, yes — dosing decisions where the renal number is borderline. It usually comes down to how much runway you have before discharge, and here we had very little. Interviewer: At the fourth point, the bruise at discharge — how did that factor in? Participant: It didn't really change anything clinically since she wasn't on the drug yet. The bigger factor was still the pending renal result. We noted the bruise for the outpatient team and moved on. Interviewer: If the fall-risk assessment had come back clearly low instead of borderline, would you have decided differently? Participant: Probably, yes — a clear low score would have resolved a lot of the hesitation at the first decision point. Interviewer: If the comparator patient's chart details had been available immediately, do you think the outcome would have changed? Participant: Possibly the family conversation would have gone faster, but I don't think it would have changed the actual treatment timing much — the renal question was separate. Interviewer: Looking back, what would you tell a colleague facing something similar? Participant: Chase down unexplained symptoms before they get labeled as routine falls, and don't assume a story about another patient applies to yours without checking the details. Beyond that, I think reasonable people could have made different calls at almost every step here.

_ranker=rrf · t=0.04 · k=25 → 25 in context · 8192 ctx · emb 1.54s · gen 210.88s · total 214.3s_

**Retrieved** (ranked by store ranker):
1. **From Mindless to Mindful Practice — Cognitive Bias and Clinical Decision Making.pdf** — 0.0323 (rrf) — _#### june 27, 2013 the resident and the attending physician regarding the management of posterio_
2. **Mitigating cognitive bias with clinical decision support systems  an experimental study.pdf** — 0.0240 (rrf) — _# support Student 52 female (69.3 %) 75 (72.8 %) 25.53 (SD = 5.02) 25 (range = 19–52) 4.57 (SD =_
3. **Journal of Clinical Nursing - 2023 - Jala - Cognitive bias during clinical decision‐making and its influence on patient.pdf** — 0.0213 (rrf) — _# decisionmaking examined the relationship between nurses' bias to healthcare disparities. In th_
4. **Clinical-decision-making--Cognitive-biases-and-heu_2025_The-American-Journal.pdf** — 0.0212 (rrf) — _## Uwe Dulleck, PhD revealed that if a patient was having lower abdominal pain with a temperatur_
5. **Goh et al. (2025) Physician clinical decision modification and bias assessment in a randomized controlled trial of AI assistance.pdf** — 0.0209 (rrf) — _# fi cation ecisionquestions,basedonevidencehttps://doi.org/10.1038/s43856-025-00781-2 sentation_
6. **Cognitive bias and decision aid use under stressful conditions.pdf** — 0.0203 (rrf) — _### cKniff At the time of this study, CDSS were available to nurses in the form of computers and_
7. **Vicente & Matute (2023) Humans inherit artificial intelligence biases.pdf** — 0.0188 (rrf) — _# Experiment 1 Method. the methodology reported in this article and the experiments were conduct_
8. **natesan-et-al-2016-cognitive-bias-in-usability-testing.pdf** — 0.0186 (rrf) — _## Types of Cognitive Biases with?” vs. “What did you think of the material the device was made _
9. **Azzopardi (2021). Cognitive Biases in Search.pdf** — 0.0185 (rrf) — _# 4 DISCUSSION AND CRITICAL REFLECTION | was deemed as not helpful. So, if a participant said it_
10. **Vicente & Matute (2023) Humans inherit artificial intelligence biases.pdf** — 0.0183 (rrf) — _# Experiment 3 e postexperimental questions in Experiment 3 were the same as in Experiment 2, bu_
11. **Cognitive bias in the cockpit A deadly false sense of normality Sam OConnor (1).pdf** — 0.0180 (rrf) — _# 1. Introduction th On the evening of 7 board was on final approach to runway 28 Right in San F_
12. **Cognitive bias in the cockpit A deadly false sense of normality Sam OConnor (1).pdf** — 0.0179 (rrf) — _# 6. Conclusion fter a gap in the research was discovered aimed to establish what the most commo_
13. **Rastogi et al. (2022) Deciding fast and slow_The role of cognitive biases in AI-assisted decision-making.pdf** — 0.0173 (rrf) — _# 4 Anchoring bias Figure 2. Results of experiment 1. time allocations in experiment 1. answer u_
14. **Cognitive bias in the cockpit A deadly false sense of normality Sam OConnor (1).pdf** — 0.0170 (rrf) — _# 5. Discussion conditions (14 out of 25) finding, t he researcher disproportionately if a large_
15. **Bucinca et al. (2021) To Trust or to Think_Cognitive Forcing Functions Can Reduce Overreliance on AI in AI-assisted Decision-making.pdf** — 0.0165 (rrf) — _# 188 task, the top performer of each batch was rewarded with a bonus of $3. Out of 260 particip_
16. **Clinical-decision-making--Cognitive-biases-and-heu_2025_The-American-Journal.pdf** — 0.0164 (rrf) — _## Uwe Dulleck, PhD learnthroughpractice.AsDanielKahnemanarguesinhisbook Fast, and Slow , expert_
17. **Goh et al. (2025) Physician clinical decision modification and bias assessment in a randomized controlled trial of AI assistance.pdf** — 0.0164 (rrf) — _# fi cation 13,14 studies . In either case, our statistical model (Supplementary Table 6) showed_
18. **parasuraman-manzey-2010-complacency-and-bias-in-human-use-of-automation-an-attentional-integration.pdf** — 0.0163 (rrf) — _# Complacency and Bias in Human Use of Automation: An Attentional Integration 400 and management_
19. **natesan-et-al-2016-cognitive-bias-in-usability-testing.pdf** — 0.0161 (rrf) — _## Types of Cognitive Biases criticize themselves rather than the device. Priming Effect. The te_
20. **Mitigating cognitive bias with clinical decision support systems  an experimental study.pdf** — 0.0160 (rrf) — _# support were adapted from translated into German scenario in less the use of heuristics for on_
21. **parasuraman-manzey-2010-complacency-and-bias-in-human-use-of-automation-an-attentional-integration.pdf** — 0.0160 (rrf) — _# Complacency and Bias in Human Use of Automation: An Attentional Integration - 402 discounting _
22. **Journal of Clinical Nursing - 2023 - Jala - Cognitive bias during clinical decision‐making and its influence on patient.pdf** — 0.0159 (rrf) — _# 4on patient outcomes in the emergency department: A scoping We used the eligibility and exclus_
23. **Goh et al. (2025) Physician clinical decision modification and bias assessment in a randomized controlled trial of AI assistance.pdf** — 0.0159 (rrf) — _# fi cation afterward. I also felt attack in his early 60 Afterreviewingthecasevignetteandassoci_
24. **Clinical-decision-making--Cognitive-biases-and-heu_2025_The-American-Journal.pdf** — 0.0158 (rrf) — _## Uwe Dulleck, PhD ical decisionmaking \[ The fi ndings of our study have signi patient health _
25. **The_Handbook_of_Evolutionary_Psychology.pdf** — 0.0158 (rrf) — _# to Dangers from Humans speed, brute strength, sensory acuity, and apparent det allies to attac_

{
  "analysis_metadata": {
    "task": "cognitive_bias_analysis",
    "interview_speakers_detected": ["Interviewer", "Participant"],
    "retrieved_corpus_support_used": false,
    "analysis_scope_note": "Reviewed the full transcript for affirmative evidence of cognitive bias in the participant's decision-making during an inpatient admission. Several plausible bias mechanisms were considered as candidates, but none met the threshold for an identified occurrence because the reasoning was either appropriately evidence-checking or explained by legitimate clinical uncertainty, incomplete information, and discharge-time constraints."
  },
  "identified_bias_summary": [],
  "identified_occurrences": [],
  "candidate_biases": [
    {
      "candidate_id": "cand_001",
      "classification_status": "candidate",
      "proposed_bias_label": "anchoring",
      "alternative_labels": ["anchoring bias", "focalism"],
      "taxonomy_status": "established_label",
      "speaker_or_attributed_person": "Participant",
      "possible_decision_episode_label": "Initial decision to defer anticoagulation after new atrial fibrillation",
      "supporting_interview_quote": "The lightheadedness before the fall. If that fall had a cardiac cause we hadn't identified, starting anticoagulation without understanding it felt premature.",
      "plausible_mechanism": "The salient fall with preceding lightheadedness may have served as an anchor, causing the stroke-risk scores (CHA2DS2-VASc 4) to be insufficiently adjusted away from.",
      "why_not_identified": "The participant explicitly weighed the scores, sought a fall-risk assessment and cardiology opinion, and described the decision as a judgment call under incomplete history; no affirmative evidence of over-reliance or failure to adjust was present."
    },
    {
      "candidate_id": "cand_002",
      "classification_status": "candidate",
      "proposed_bias_label": "omission bias",
      "alternative_labels": ["action-omission bias", "default to inaction"],
      "taxonomy_status": "established_label",
      "speaker_or_attributed_person": "Participant",
      "possible_decision_episode_label": "Final discharge without starting anticoagulation",
      "supporting_interview_quote": "I finalized the discharge without starting treatment and arranged outpatient follow-up, which ended up being three weeks out rather than the two we'd hoped for.",
      "plausible_mechanism": "A preference for inaction may have distorted the weighting of stroke reduction versus bleeding risk, leading to no treatment despite scores leaning toward treating.",
      "why_not_identified": "The transcript supplies legitimate non-bias explanations: unexplained presyncope, borderline fall risk, and a pending renal result. The participant also said waiting was not because he thought it was inherently safer, which argues against an action-omission distortion."
    },
    {
      "candidate_id": "cand_003",
      "classification_status": "candidate",
      "proposed_bias_label": "availability heuristic",
      "alternative_labels": ["availability bias"],
      "taxonomy_status": "established_label",
      "speaker_or_attributed_person": "Participant",
      "possible_decision_episode_label": "Comparison requested by patient's daughter after another patient's bleeding complication",
      "supporting_interview_quote": "On day two, one of the nurses mentioned that a patient down the hall had a bleeding complication on anticoagulation the month before. My patient's daughter had heard about it and asked me directly how similar the situations were.",
      "plausible_mechanism": "The vivid recent bleeding event could have inflated perceived bleeding risk for this patient.",
      "why_not_identified": "The participant did not rely on the anecdote; he asked the resident to verify the other patient's renal function and medications, and later said the comparison did not change actual treatment timing much."
    },
    {
      "candidate_id": "cand_004",
      "classification_status": "candidate",
      "proposed_bias_label": "search satisficing",
      "alternative_labels": ["premature closure", "satisficing"],
      "taxonomy_status": "established_label",
      "speaker_or_attributed_person": "Participant",
      "possible_decision_episode_label": "Workup of unexplained pre-fall lightheadedness before discharge",
      "supporting_interview_quote": "I asked for a fall-risk assessment and held off committing to a start date until we had more to go on. The formal assessment came back borderline — not clearly low, not clearly high.",
      "plausible_mechanism": "After receiving a borderline fall-risk score and a noncommittal cardiology curbside, the participant may have accepted an incomplete evaluation rather than pursuing further cardiac or orthostatic workup.",
      "why_not_identified": "The transcript does not show a clear stopping rule or dismissal of other possibilities; the participant continued to request renal testing and arranged follow-up. Discharge-time constraints and legitimate uncertainty explain the limited inpatient workup."
    }
  ],
  "no_supported_biases_found": true,
  "limitations": [
    "Analysis is based solely on the participant's retrospective self-report; it may not capture unspoken biases.",
    "The transcript contains no outcome data that could otherwise suggest biased reasoning.",
    "Retrieved scientific passages were used only as a general framework; no occurrence reached the threshold for formal corpus-grounded classification."
  ]
}
